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Previews
ular transcription interference and impaired proteaso-Polyglutamines Stop Traffic: Axonal
mal degradation (Ross, 2002).Transport as a Common Target A role for transcription dysregulation is consistent with
a wide range of studies demonstrating the nucleus asin Neurodegenerative Diseases
a key site of pathology (La Spada and Taylor, 2003).
However, an enigmatic but very well-documented fea-
ture of HD neuropathology has been the superior corre-
lation of neuropil aggregates with neurodegeneration in
In this issue of Neuron, two papers provide evidence comparison to nuclear aggregates. This phenomenon
that polyglutamine (polyQ) proteins disrupt axonal has been observed in cortical, substantia nigra, and
transport. Gunawardena et al. show that normal levels lateral globus pallidus neurons projecting to the striatum
of huntingtin are required for proper axonal transport in R6/2 and knockin mouse models of HD as well as in
in Drosophila. In addition, expression of expanded human patients (Li et al., 2001). These findings, together
polyQ proteins disrupts axonal transport in larval neu- with evidence for cytosolic localization of full-length
rons. Szebenyi and colleagues find that polyQ proteins huntingtin protein and its association with cytoskeletal
directly inhibit fast axonal transport using axoplasm and vesicular structures, have been compelling reasons
from the squid giant axon and suggest that axonal to consider a role for axonal transport in HD pathogene-
transport defects may be a common feature of polyQ sis, perhaps via a loss of function of normal huntingtin
disease pathogenesis. protein. In the case of HD, a loss-of-function component
has been difficult to evaluate because the normal func-
tion of huntingtin is unknown. Mice completely lackingNeurons face a daunting transportation challenge.
huntingtin die early in embryogenesis. Intriguingly, how-Newly synthesized proteins must be carried long dis-
ever, conditional knockout of huntingtin in the adulttances down axons to synapses, and returning retro-
brain produces neurodegeneration (Dragatsis et al.,grade signals necessarily travel the same path. In the
2000). Results from the conditional knockouts, togethercase of motor neurons, the cell body may be as far as
with several other recent studies, suggest that loss of
one meter away from the synapse. Alterations of either
normal huntingtin may contribute to neurodegeneration.
anterograde or retrograde transport would thus seem
Gunawardena et al. now take an important step for-
plausible substrates for producing dysfunction, or even
ward in the dissection of normal huntingtin function by
death, of neurons. Indeed, abnormalities in axonal trans-
demonstrating that decreasing the levels of Drosophila
port have been suspected for some time in amyotrophic
huntingtin by expression of transgenic RNAi induces
lateral sclerosis, a degenerative disorder that particu- abnormal accumulations of cellular organelles in larval
larly targets motor neurons. Evidence from several neurons (Gunawardena et al., 2003 [this issue of Neu-
groups has recently confirmed the importance of normal ron]). These accumulations are termed axonal block-
axonal transport for maintaining motor neuron viability. ages, and their presence correlates well with disruption
Mutations in dynactin, a protein required for axonal of axonal transport. Gunawardena et al. also pursue
transport, have been described in patients with motor the toxic gain of function thought to occur in HD by
neuron disease (Puls et al., 2003). Discovery of dynactin expressing normal and mutant forms of huntingtin. As
mutations in these patients correlates nicely with previ- with loss of huntingtin function, axonal blockages are
ous work showing that dominant disruption of dynactin seen with expression of mutant huntingtin. These strik-
function produces motor neuron degeneration in mice ing results suggest that both gain and loss of function
(LaMonte et al., 2002). Similarly, two mouse models of target the same cellular process, axonal transport, in HD.
motor neuron disease result from allelic amino acid sub- Because Gunawardena et al. use the presence of axo-
stitution mutations in dynein, the retrograde axonal mo- nal blockages to demonstrate axonal transport defects,
tor protein (Hafezparast et al., 2003). the precise nature of the transport abnormalities could
The polyQ disorders include nine neurodegenerative not be determined. In contrast, Szebenyi et al. rely upon
diseases that are produced by a distinctive mutational the well-characterized squid giant axon system to study
mechanism, with Huntington’s disease (HD) being the the effect of polyQ expansions upon fast axonal trans-
most common and well known of the group (Zoghbi and port (Szebenyi et al., 2003 [this issue of Neuron]). Inter-
Orr, 2000). Expansion of CAG repeat sequences within estingly, polyQ length-dependent inhibition of antero-
the coding region of unrelated proteins produces a toxic grade and retrograde transport is observed in isolated
gain of function that eventually leads to the demise of squid axoplasm with truncated versions of the hunting-
defined subsets of neurons. A toxic dominant mecha- tin protein and the androgen receptor (AR), the latter
nism is supported by the dominant mode of inheritance being the causal protein in X-linked spinal and bulbar
and the ability of expanded, but not unexpanded, pro- muscular atrophy (SBMA), a lower motor neuron dis-
teins to produce neurodegeneration in experimental or- ease. In addition to evaluating axonal transport, these
ganisms. In contrast to motor neuron disease, theories workers produced SH-SY5Y cell lines stably transfected
on the pathogenesis of polyQ toxicity have not typically with full-length AR Q20 and AR Q56 expression con-
focused on abnormalities in axonal transport but have structs. The SH-SY5Y lines were then used to assess
morphological differentiation and motor protein distri-included a variety of alternative cellular targets, in partic-
Neuron
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bution. These experiments indicated that BDNF-driven bellar ataxias should facilitate further testing of the role
differentiation of SH-SY5Y cells yielded significantly of axonal transport abnormalities in polyQ neurotoxicity
shorter neuritic processes in the stable lines expressing and thereby allow investigators to establish how early
polyQ-expanded AR, but without a significant difference and critical an event axonal dysfunction really is in
in cell survival. In one SH-SY5Y stably transfected line, these disorders.
a more pronounced defect in neurite outgrowth was
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polyQ-mediated axonal transport alterations or motor
protein dysfunction initiate apoptotic activation, yielding
active caspases and other proteases that then cleave
polyQ proteins to generate truncated polyQ-containing
peptides. How these events intertwine with the pre- Intracellular Ca2 Release
sumed nuclear pathology of huntingtin fragments in HD and Ischemic Axon Injury:and the ligand-responsive AR in SBMA remains to be
clarified. The Trojan Horse Is Back
In summary, the papers by Szebenyi et al. and Guna-
wardena et al. nicely demonstrate that expression of
polyQ proteins can poison axonal transport directly in
Ischemic injury of cells in the central nervous systemisolated axoplasm and create axonal blockages, in vivo
is typically set in motion by influx of extracellular Ca2.hallmarks of disrupted axonal transport. These findings
In this issue of Neuron, Stys and colleagues proposeclearly add the polyQ disorders to the list of neurodegen-
that ischemic injury in spinal cord axons is partly theerative diseases in which axonal transport abnormalities
result of ryanodine receptor-mediated release of Ca2have been implicated. The challenge now is to reconcile
from the endoplasmic reticulum (ER), a site of intracel-disruption of cytoplasmic axonal transport with the dem-
lular Ca2 storage.onstrated nuclear toxicity of polyQ proteins and to arrive
at a comprehensive model of polyQ toxicity. The excel-
lent animal models available for HD and the spinocere- Our humbling failure to develop clinically effective neu-
